Reshaping the shared epitope hypothesis: HLA-associated risk for rheumatoid arthritis is encoded by amino acid substitutions at positions 67–74 of the HLA–DRB1 molecule
Corresponding Author
Niek de Vries
University Medical Center Utrecht, Utrecht, The Netherlands, and Academic Medical Center/University of Amsterdam, Amsterdam, The Netherlands
Department of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, F4-218, PO Box 22700, 1100 DE Amsterdam, The NetherlandsSearch for more papers by this authorHenk Tijssen
University Medical Center St. Radboud, Nijmegen, The Netherlands
Search for more papers by this authorPiet L. C. M. van Riel
University Medical Center St. Radboud, Nijmegen, The Netherlands
Search for more papers by this authorLeo B. A. van de Putte
University Medical Center St. Radboud, Nijmegen, The Netherlands
Search for more papers by this authorCorresponding Author
Niek de Vries
University Medical Center Utrecht, Utrecht, The Netherlands, and Academic Medical Center/University of Amsterdam, Amsterdam, The Netherlands
Department of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, F4-218, PO Box 22700, 1100 DE Amsterdam, The NetherlandsSearch for more papers by this authorHenk Tijssen
University Medical Center St. Radboud, Nijmegen, The Netherlands
Search for more papers by this authorPiet L. C. M. van Riel
University Medical Center St. Radboud, Nijmegen, The Netherlands
Search for more papers by this authorLeo B. A. van de Putte
University Medical Center St. Radboud, Nijmegen, The Netherlands
Search for more papers by this authorAbstract
Objective
To further analyze the association of HLA–DRB1 alleles with disease susceptibility in recent-onset rheumatoid arthritis (RA).
Methods
One hundred sixty-seven Caucasian RA patients and 166 healthy controls were typed for HLA–DRB1.
Results
The association of susceptibility to RA with the group of alleles encoding the shared epitope susceptibility sequences (SESSs) was confirmed in recent-onset RA. Among non-SESS alleles, DRB1*07, *1201, *1301, and *1501 showed significant protective effects. Even after correction for the influence of SESS alleles, significant independent protective effects of DRB1 alleles were observed. Protective alleles shared a third hypervariable region motif. Independent homozygosity effects were observed both for susceptibility and for protective alleles.
Conclusion
Nonsusceptibility alleles differ significantly with regard to RA risk. Protective alleles show clear homology at positions 67–74, often encoding isoleucine at position 67 or aspartic acid at position 70. Susceptibility and protective alleles both show homozygosity effects. Based on these results and on data reported in the literature, in order to incorporate the finding of differential risks among nonsusceptibility alleles, we propose to reshape the shared epitope hypothesis as follows: HLA-associated risk for RA is encoded by amino acid substitutions at positions 67–74 of the HLA–DRB1 molecule.
REFERENCES
- 1 Winchester R. The molecular basis of susceptibility to rheumatoid arthritis. Adv Immunol 1994; 56: 389–466.
- 2 Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis: an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987; 30: 1205–13.
- 3 Weyand CM, Xie C, Goronzy JJ. Homozygosity for the HLA-DRB1 allele selects for extraarticular manifestations in rheumatoid arthritis. J Clin Invest 1992; 89: 2033–9.
- 4 Thomson W, Harrison B, Ollier B, Wiles N, Payton T, Barrett J, et al. Quantifying the exact role of HLA–DRB1 alleles in susceptibility to inflammatory polyarthritis: results from a large, population-based study. Arthritis Rheum 1999; 42: 757–62.
- 5 Nepom GT, Seyfried CE, Holbeck SL, Wilske KR, Nepom BS. Identification of HLA-Dw14 genes in DR4+ rheumatoid arthritis. Lancet 1986; 2: 1002–5.
- 6 Gough A, Faint J, Salmon M, Hassell A, Wordsworth P, Pilling D, et al. Genetic typing of patients with inflammatory arthritis at presentation can be used to predict outcome. Arthritis Rheum 1994; 37: 1166–70.
- 7 Schiff B, Mizrachi Y, Orgad S, Yaron M, Gazit E. Association of HLA-Aw31 and HLA-DR1 with adult rheumatoid arthritis. Ann Rheum Dis 1982; 41: 403–4.
- 8 Rønningen KS, Spurkland A, Egeland T, Iwe T, Munthe E, Vartdal F, et al. Rheumatoid arthritis may be primarily associated with HLA-DR4 molecules sharing a particular sequence at residues 67-74. Tissue Antigens 1990; 36: 235–40.
- 9 González A, Nicovani S, Massardo L, Bull P, Rodríguez L, Jacobelli S. Novel genetic markers of rheumatoid arthritis in Chilean patients, by DR serotyping and restriction fragment length polymorphism analysis. Arthritis Rheum 1992; 35: 282–9.
- 10 Wakitani S, Imoto K, Murata N, Toda Y, Ogawa R, Ochi T. The homozygote of HLA-DRB1*0901, not its heterozygote, is associated with rheumatoid arthritis in Japanese. Scand J Rheumatol 1998; 27: 381–2.
- 11 Sattar MA, al-Saffar M, Guindi RT, Sugathan TN, White AG, Behbehani K. Histocompatibility antigens (A, B, C, and DR) in Arabs with rheumatoid arthritis. Dis Markers 1990; 8: 11–5.
- 12 Gao X, Brautbar C, Gazit E, Segal R, Naparstek Y, Livneh A, et al. A variant of HLA–DR4 determines susceptibility to rheumatoid arthritis in a subset of Israeli Jews. Arthritis Rheum 1991; 34: 547–51.
- 13 Wakitani S, Murata N, Toda Y, Ogawa R, Kaneshige T, Nishimura Y, et al. The relationship between HLA-DRB1 alleles and disease subsets of rheumatoid arthritis in Japanese. Br J Rheumatol 1997; 36: 630–6.
- 14 Zanelli E, Gonzalez GM, David CS. Could HLA-DRB1 be the protective locus in rheumatoid arthritis? Immunol Today 1995; 16: 274–8.
- 15 De Vries N, van Elderen C, Tijssen H, van Riel PLCM, van de Putte LBA. No support for HLA–DQ encoded susceptibility in rheumatoid arthritis. Arthritis Rheum 1999; 42: 1621–7.
- 16 De Vries N, van Elderen C, Tijssen H, van Riel PLCM, van de Putte LBA. Role of HLA–DQ in rheumatoid arthritis susceptibility [reply]. Arthritis Rheum 2000; 43: 947–8.
- 17 Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315–24.
- 18 Bodmer JG, Marsh SE, Albert ED, Bodmer WF, Dupont B, Erlich HA, et al. Nomenclature report for factors of the HLA system, 1991. Tissue Antigens 1992; 39: 161–73.
- 19 K Tsuji, M Aizawa, T Sasazuki, editors. HLA 1991. Proceedings of the 11th International Histocompatibility Workshop. Oxford: Oxford University Press; 1992.
- 20 Khalil I, d'Auriol L, Gobet M, Morin L, Lepage V, Deschamps I, et al. A combination of HLA-DQ beta Asp57-negative and HLA DQ alpha Arg52 confers susceptibility to insulin-dependent diabetes mellitus. J Clin Invest 1990; 85: 1315–9.
- 21 Haider MZ, Shaltout A, Qabazard K, Dorman J. Prevalence of human leukocyte antigen DQA1 and DQB1 alleles in Kuwaiti Arab children with type 1 diabetes mellitus. Clin Genet 1999; 56: 450–6.
- 22 Sanchez B, Moreno I, Magarino R, Garzon M, Gonzalez MF, Garcia A, et al. HLA-DRw10 confers the highest susceptibility to rheumatoid arthritis in a Spanish population. Tissue Antigens 1990; 36: 174–6.
- 23 Yelamos J, Garcia-Lozano JR, Moreno I, Aguilera I, Gonzalez MF, Garcia A, et al. Association of HLA–DR4-Dw15 (DRB1∗︁0405) and DR10 with rheumatoid arthritis in a Spanish population. Arthritis Rheum 1993; 36: 811–4.
- 24 Mehra NK, Vaidya MC, Agarwal A, Malaviya AN. HLA-DR antigens in rheumatoid arthritis in North India. Tissue Antigens 1982; 20: 300–2.
- 25 Lang B, Melchers I, Urlacher A, Tanzi FR, Kohlbrenner S, Tongio MM, et al. HLA-DR1 and DRw6 association in DR4-negative rheumatoid arthritis patients. Rheumatol Int 1990; 10: 171–5.
- 26 Seglias J, Li EK, Cohen MG, Wong RWS, Potter PK, So AK. Linkage between rheumatoid arthritis susceptibility and the presence of HLA–DR4 and DRβ allelic third hypervariable region sequences in southern Chinese persons. Arthritis Rheum 1992; 35: 163–7.
- 27 Nelson JL, Hansen JA, Singal D, Buchanan WW, Marshall W, Larsen BA, et al. Rheumatoid arthritis. In: K Tsuji, M Aizawa, T Sasazuki, editors. HLA 1991. Proceedings of the 11th international histocompatibility workshop. Oxford: Oxford University Press; 1992. p. 772–4.
- 28 Okubo H, Itou K, Watanabe N, Kashiwagi N, Obata F. Analysis of HLA-DR gene frequencies in Japanese cases of juvenile rheumatoid arthritis and rheumatoid arthritis by oligonucleotide DNA typing. Rheumatol Int 1993; 13: 65–9.
- 29 Panayi GS, Wooley P, Batchelor JR. Genetic basis of rheumatoid disease: HLA antigens, disease manifestations, and toxic reactions to drugs. Br Med J 1978; 2: 1326–8.
- 30 Gran JT, Husby G, Thorsby E. HLA DR antigens in rheumatoid arthritis. Scand J Rheumatol 1983; 12: 241–5.
- 31 Wordsworth BP, Lanchbury JS, Sakkas LI, Welsh KI, Panayi GS, Bell JI. HLA-DR4 subtype frequencies in rheumatoid arthritis indicate that DRB1 is the major susceptibility locus within the HLA class II region. Proc Natl Acad Sci U S A 1989; 86: 10049–53.
- 32 El-Gabalawy HS, Goldbach-Mansky R, Smith D II, Arayssi T, Bale S, Gulko P, et al. Association of HLA alleles and clinical features in patients with synovitis of recent onset. Arthritis Rheum 1999; 42: 1696–705.
- 33 Seidl C, Koch U, Buhleier T, Frank R, Moller B, Markert E, et al. HLA-DRB1*04 subtypes are associated with increased inflammatory activity in early rheumatoid arthritis. Br J Rheumatol 1997; 36: 941–4.
- 34 Del Rincón I, Escalante A. HLA–DRB1 alleles associated with susceptibility or resistance to rheumatoid arthritis, articular deformities, and disability in Mexican Americans. Arthritis Rheum 1999; 42: 1329–38.
- 35 Mattey DL, Dawes PT, Gonzalez-Gay MA, Garcia-Porrua C, Thomson W, Hajeer AH, et al. HLA-DRB1 alleles encoding an aspartic acid at position 70 protect against development of rheumatoid arthritis. J Rheumatol 2001; 28: 232–9.
- 36 Reviron D, Perdriger A, Toussirot E, Wendling D, Balandraud N, Guis S, et al. Influence of shared epitope–negative HLA–DRB1 alleles on genetic susceptibility to rheumatoid arthritis. Arthritis Rheum 2001; 44: 535–40.
- 37 Massardo L, Aguirre V, Garcia ME, Cervila V, Nicovani S, Gonzalez A, et al. Clinical expression of rheumatoid arthritis in Chilean patients. Semin Arthritis Rheum 1995; 25: 203–13.
- 38 Amar A, Kwon OJ, Motro CS, Witt CS, Bonne-Tamit B, Gabison R, et al. Molecular analysis of HLA class II polymorphisms among different ethnic groups in Israel. Hum Immunol 1999; 60: 723–30.
- 39 Salmon M, Wordsworth P, Emery P, Tunn E, Bacon PA, Bell JI. The association of HLA-DRB alleles with self-limiting and persistent forms of early symmetrical polyarthritis. Br J Rheumatol 1993; 32: 628–30.
